Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update reflects version control activity rather than a change to the study content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s technical release/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a platform update rather than any change to the study information.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study content.SummaryDifference0.1%

- Check97 days agoChange DetectedA new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.